Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | EIF2AK2 |
| Upstream (Parents) |
|---|
| (<<) BMPR1A → EIF2AK2 |
| (<<) CLCF1 → EIF2AK2 |
| (<<) DNAJA1 → EIF2AK2 |
| (<<) GLTPD1 → EIF2AK2 |
| (<<) GPX4 → EIF2AK2 |
| (<<) MAP2K1 → EIF2AK2 |
| (<<) MAPK1 → EIF2AK2 |
| (<<) PPRC1 → EIF2AK2 |
| (<<) SEPW1 → EIF2AK2 |
| (<<) SHFM1 → EIF2AK2 |
| (<<) SMAD5 → EIF2AK2 |
| (<<) SMARCC2 → EIF2AK2 |
| (<<) SP3 → EIF2AK2 |
| (<<) SPPL2B → EIF2AK2 |
| (<<) TMEM39B → EIF2AK2 |
| (<<) TRIM32 → EIF2AK2 |
| Downstream (Children) |
|---|
| EIF2AK2 → CCNA1 (>>) |
| EIF2AK2 → E2F4 (>>) |
| EIF2AK2 → FOSL1 (>>) |
| EIF2AK2 → FOXA2 (>>) |
| EIF2AK2 → ILKAP (>>) |
| EIF2AK2 → MAP1B (>>) |
| EIF2AK2 → MAPKAP1 (>>) |
| EIF2AK2 → MMP15 (>>) |
| EIF2AK2 → MYL3 (>>) |
| EIF2AK2 → MYO10 (>>) |
| EIF2AK2 → NOC3L (>>) |
| EIF2AK2 → PPP2R5B (>>) |
| EIF2AK2 → PRKX (>>) |
| EIF2AK2 → RBKS (>>) |
| EIF2AK2 → SYNPO (>>) |
| EIF2AK2 → TGFB1 (>>) |
| EIF2AK2 → UBE2L6 (>>) |
